Please note: The information displayed on this page might be outdated.
Targovax: Oncolytic adenovirus armed w immune stimulating transgene targeting basket of I-O indications. Strong results from Part 1 (ONCOS-102/Keytruda combo) trial in anti-PD1 refractory melanoma: 33% ORR in 9 pts: 1 CR, 2 PRs; immune act. in all 9 pts. Upcoming milestones: randomized data, Ph 1b/2 (mesothelioma, n=31) w/chemo: Jan 2020; Ph 1, Part 2 data (melanoma comb w/Keytruda, n=21): 1H2020; updates from collab partners in peritoneal metastasis & prostate exp 2020
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Disease Space
Anti-infectives, Antivirals, Immuno-Oncology, Immunotherapy, Oncology
Finance
Pre-earnings
Industry
Biotechnology
Listing
Europe, Public
Market Cap
<100MM
Therapeutic Modalities
Platform Technology, Vaccine
Website:
Profiles:
Address:
Lilleakerveien 2 C
Oslo, NO-0283
Norway

Company Participants at 2nd Solebury Trout Virtual Global Healthcare Conference Series

Øystein Soug
Targovax, CEO
20 years in international banking and industry, the last six of which as CFO of Algeta ASA and was the former CFO of Targovax ASA. Øystein Soug is the former CFO of Algeta, a Norwegian oncology biotech company which was sold to Bayer for USD 2.9 billion in 2014. Prior to joining Algeta in 2008 Mr. Soug worked for six years at Orkla, lastly as CFO of Orkla’s Russian division. Mr. Soug started his career as a banker with Credit Suisse and with the European Bank for Reconstruction and Development. Mr. Soug received an MSc in Economics and Financial Markets from Universität St. Gallen in Switzerland in 1997.

Top 10 Holders of Targovax ASA

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Nordea Investment Management AB (Norway) 7.74 5,023,498 4.73 Funds 7/31/20
Fjärde AP-fonden 4.73 3,000,000 2.83 Funds 6/30/20
KLP Kapitalforvaltning AS 1.36 1,031,244 0.97 Stakes 12/31/19
Storebrand Asset Management AS 0.47 295,000 0.28 Funds 8/31/20
Handelsbanken Fonder AB 0.16 99,669 0.09 Funds 8/31/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.